Burning Rock Biotech Ltd
BNR23.390USD
+1.690+7.79%
收盘 12/22, 16:00（美东）报价延迟15分钟
211.19M总市值
亏损市盈率 TTM
关于 Burning Rock Biotech Ltd 公司
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Burning Rock Biotech Ltd简介
公司代码BNR
公司名称Burning Rock Biotech Ltd
上市日期Jun 12, 2020
CEOHan (Yusheng)
员工数量674
证券类型Depository Receipt
年结日Jun 12
公司地址No. 5 Xingdao Ring Road North
城市GUANGZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
国家China
邮编510005
电话
网址https://www.brbiotech.com/
公司代码BNR
上市日期Jun 12, 2020
CEOHan (Yusheng)
Burning Rock Biotech Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Xiaozhi Hu
Ms. Xiaozhi Hu
Senior Director in Finance
Senior Director in Finance
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Gang Lu
Mr. Gang Lu
Director
Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Xiaozhi Hu
Ms. Xiaozhi Hu
Senior Director in Finance
Senior Director in Finance
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
收入明细
FY2019
FY2018
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
China (Mainland)
0.00
0.00%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 3 小时前
更新时间: 3 小时前
持股股东
股东类型
持股股东
持股股东
占比
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
其他
57.55%
持股股东
持股股东
占比
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
其他
57.55%
股东类型
持股股东
占比
Private Equity
20.91%
Hedge Fund
11.37%
Investment Advisor/Hedge Fund
6.30%
Bank and Trust
5.14%
Corporation
3.92%
Investment Advisor
0.73%
Research Firm
0.58%
其他
51.05%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
39
3.80M
46.56%
--
2025Q3
49
4.65M
47.27%
-5.46K
2025Q2
58
4.65M
51.33%
-759.34K
2025Q1
65
5.41M
53.38%
+589.94K
2024Q4
74
5.54M
50.70%
+348.38K
2024Q3
93
5.26M
57.60%
-7.02K
2024Q2
108
5.27M
61.36%
-5.69K
2024Q1
121
5.30M
64.27%
-181.25K
2023Q4
137
5.23M
65.24%
+745.66K
2023Q3
205
5.00M
74.63%
-61.48K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Northern Light Venture Capital
1.05M
11.68%
--
--
Mar 31, 2025
Kynam Capital Management LP
994.88K
11.02%
--
--
Jun 30, 2025
Lyfe Capital
833.84K
9.24%
--
--
Mar 31, 2025
CRCM L.P.
194.77K
2.16%
-31.52K
-13.93%
Jun 30, 2025
China Merchants Bank Co Ltd
462.99K
5.13%
--
--
Mar 31, 2025
Quantum Boundary Holdings Ltd
353.92K
3.92%
+350.62K
+10637.83%
Mar 31, 2025
Amova Asset Management Americas, Inc
45.55K
0.5%
+45.55K
--
Dec 31, 2024
Amova Asset Management Co., Ltd.
43.93K
0.49%
--
--
Jun 30, 2025
Renaissance Technologies LLC
31.72K
0.35%
--
--
Jun 30, 2025
BofA Global Research (US)
29.28K
0.32%
-18.00
-0.06%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Avantis Responsible Emerging Markets Equity ETF
0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
0%
Avantis Responsible Emerging Markets Equity ETF
占比0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
占比0%
SPDR S&P Emerging Markets Small Cap ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
公告日期
类型
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
常见问题
Burning Rock Biotech Ltd的前五大股东是谁？
Burning Rock Biotech Ltd 的前五大股东如下：
Northern Light Venture Capital持有股份：1.05M，占总股份比例：11.68%。
Kynam Capital Management LP持有股份：994.88K，占总股份比例：11.02%。
Lyfe Capital持有股份：833.84K，占总股份比例：9.24%。
CRCM L.P.持有股份：194.77K，占总股份比例：2.16%。
China Merchants Bank Co Ltd持有股份：462.99K，占总股份比例：5.13%。
Northern Light Venture Capital持有股份：1.05M，占总股份比例：11.68%。
Kynam Capital Management LP持有股份：994.88K，占总股份比例：11.02%。
Lyfe Capital持有股份：833.84K，占总股份比例：9.24%。
CRCM L.P.持有股份：194.77K，占总股份比例：2.16%。
China Merchants Bank Co Ltd持有股份：462.99K，占总股份比例：5.13%。
Burning Rock Biotech Ltd的前三大股东类型是什么？
Burning Rock Biotech Ltd 的前三大股东类型分别是：
Northern Light Venture Capital
Kynam Capital Management LP
Lyfe Capital
Northern Light Venture Capital
Kynam Capital Management LP
Lyfe Capital
有多少机构持有Burning Rock Biotech Ltd(BNR)的股份？
截至2025Q4，共有39家机构持有Burning Rock Biotech Ltd的股份，合计持有的股份价值约为3.80M，占公司总股份的46.56%。与2025Q3相比，机构持股有所增加，增幅为-0.72%。
哪个业务部门对Burning Rock Biotech Ltd的收入贡献最大？
在FY2019，--业务部门对Burning Rock Biotech Ltd的收入贡献最大，创收--，占总收入的--%。
